Fuller & Thaler Asset Management’s West Pharmaceutical WST Stock Holding History

Fuller & Thaler Asset Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-700	Closed	-$70K	–	740
2018 Q2	$70K	Hold	700	–	–	﹤0.01%	647
2018 Q1	$62K	Hold	700	–	–	﹤0.01%	658
2017 Q4	$69K	Hold	700	–	–	﹤0.01%	571
2017 Q3	$67K	Buy	+700	New	+$63.3K	﹤0.01%	535
2016 Q1	–	Sell	-600	Closed	-$36K	–	883
2015 Q4	$36K	Sell	600 -500	-45%	-$30.1K	﹤0.01%	673
2015 Q3	$60K	Buy	+1,100	New	+$64.1K	﹤0.01%	562
2014 Q3	–	Sell	-2,500	Closed	-$105K	–	721
2014 Q2	$105K	Hold	2,500	–	–	﹤0.01%	591
2014 Q1	$110K	Buy	2,500 +500	+25%	+$23.5K	0.01%	605
2013 Q4	$98K	Hold	2,000	–	–	0.01%	529
2013 Q3	$82K	Buy	2,000 +200	+11%	+$7.63K	﹤0.01%	552
2013 Q2	$63K	Buy	+1,800	New	+$59.2K	﹤0.01%	573

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Fuller & Thaler Asset Management's WST Position: Q3 2018 in Review

Fuller & Thaler Asset Management sold out of West Pharmaceutical (WST) in Q3 2018, closing a stake of 700 shares — an estimated $70K sold.

Fuller & Thaler Asset Management first reported a position in WST in Q2 2013 and held it in 11 quarters. The position peaked at $110K in Q1 2014. 354 funds tracked by Wall St. Rank hold WST as of Q3 2018.

Fuller & Thaler Asset Management reported no remaining West Pharmaceutical position as of Q3 2018 after selling out during the quarter.
Fuller & Thaler Asset Management sold 700 West Pharmaceutical shares in Q3 2018, an estimated $70K.
Fuller & Thaler Asset Management first reported a position in West Pharmaceutical in Q2 2013 and held it in 11 quarters.
Fuller & Thaler Asset Management's West Pharmaceutical position peaked at $110K in Q1 2014.
354 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2018.

Based on Fuller & Thaler Asset Management's 13F filing for Q3 2018, filed 13 Nov 2018.